Chengnan Guo

538 total citations
38 papers, 300 citations indexed

About

Chengnan Guo is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Chengnan Guo has authored 38 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 10 papers in Hepatology and 8 papers in Molecular Biology. Recurrent topics in Chengnan Guo's work include Liver Disease Diagnosis and Treatment (15 papers), Metabolomics and Mass Spectrometry Studies (5 papers) and Diet, Metabolism, and Disease (5 papers). Chengnan Guo is often cited by papers focused on Liver Disease Diagnosis and Treatment (15 papers), Metabolomics and Mass Spectrometry Studies (5 papers) and Diet, Metabolism, and Disease (5 papers). Chengnan Guo collaborates with scholars based in China, United States and Canada. Chengnan Guo's co-authors include Tiejun Zhang, Zhenqiu Liu, Guangyun Mao, Fang Peng, Haili Wang, Jingjing Zuo, Shuzhen Zhao, Hong Fan, Xiangqing Hou and Xinyu Han and has published in prestigious journals such as Hepatology, Journal of Agricultural and Food Chemistry and Gut.

In The Last Decade

Chengnan Guo

32 papers receiving 296 citations

Peers

Chengnan Guo

EPIDE

OPHTH

RNMI

HEPAT

Sunil Pawar India

Zahid Jadoon United Kingdom

Analúcia Rampazzo Xavier Brazil

H Ajzen Brazil

Jiangshan Lian China

Bnar Talabani United Kingdom

Fayna Rodríguez‐González Spain

Hanny Yeshua Israel

Asma Al Thani Qatar

Sunil Pawar India

Chengnan Guo

96 ×0.8

EPIDE

10 ×0.2

OPHTH

28 ×0.5

13 ×0.3

RNMI

37 ×0.8

HEPAT

Citations per year, relative to Chengnan Guo Chengnan Guo (= 1×) peers Sunil Pawar

Countries citing papers authored by Chengnan Guo

Since Specialization

Citations

This map shows the geographic impact of Chengnan Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengnan Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengnan Guo more than expected).

Fields of papers citing papers by Chengnan Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengnan Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengnan Guo. The network helps show where Chengnan Guo may publish in the future.

Co-authorship network of co-authors of Chengnan Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Chengnan Guo. A scholar is included among the top collaborators of Chengnan Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengnan Guo. Chengnan Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guo, Chengnan, et al.. (2025). Dietary Saponins as Antiaging Agents: A Systematic Review of Molecular Mechanisms, Nutritional Intervention, and Product Development. Journal of Agricultural and Food Chemistry. 73(49). 30990–31015.

Huang, Jiayi, Chenyu Liang, Yankun Liu, et al.. (2025). The association between metabolic syndrome and risk of severe infection: A population-based cohort study. Annals of Epidemiology. 110. 107–113.

Guo, Chengnan, Zhenqiu Liu, Yinan Zhang, et al.. (2025). The trend in incidence of non-alcoholic fatty liver disease and its impact on cirrhosis and liver cancer: An analysis from Global Burden of Disease 2021. Public Health. 242. 79–86. 1 indexed citations

Liang, Chenyu, Jiayi Huang, Haili Wang, et al.. (2025). Association between triglyceride-glucose related indices and severe infection requiring hospital admission or resulting in mortality among individuals with metabolic dysfunction-associated steatotic liver disease. Clinical Nutrition. 49. 1–10. 1 indexed citations

Wang, Haili, Zhenqiu Liu, Hong Fan, et al.. (2024). Association between biological aging and the risk of mortality in individuals with non-alcoholic fatty liver disease: A prospective cohort study. Archives of Gerontology and Geriatrics. 124. 105477–105477. 7 indexed citations

Guo, Chengnan, Zhenqiu Liu, Hong Fan, et al.. (2024). Machine-learning–based plasma metabolomic profiles for predicting long-term complications of cirrhosis. Hepatology. 81(1). 168–180. 14 indexed citations

Wang, Haili, Zhenqiu Liu, Hong Fan, et al.. (2024). Association between advanced fibrosis and epigenetic age acceleration among individuals with MASLD. Journal of Gastroenterology. 60(3). 306–314. 3 indexed citations

Guo, Chengnan, Zhenqiu Liu, Xin Zhang, et al.. (2024). Global, regional, and national epidemiology of hepatoblastoma in children from 1990 to 2021: a trend analysis. Hepatology International. 19(1). 156–165. 4 indexed citations

Guo, Chengnan, et al.. (2024). Serum Branched-Chain Amino Acids and Long-Term Complications of Liver Cirrhosis: Evidence from a Population-Based Prospective Study. Nutrients. 16(14). 2295–2295. 1 indexed citations

10.

Zhang, Xin, Zhenqiu Liu, Hong Fan, et al.. (2024). Prevalence of nonalcoholic fatty liver disease and liver cirrhosis in Chinese adults with type 2 diabetes mellitus. Journal of Diabetes. 16(5). e13564–e13564. 4 indexed citations

11.

Guo, Chengnan, Zhenqiu Liu, Chunqing Lin, et al.. (2023). Global epidemiology of early-onset liver cancer attributable to specific aetiologies and risk factors from 2010 to 2019. Journal of Global Health. 13. 4167–4167. 13 indexed citations

12.

Liu, Zhenqiu, Chunqing Lin, Xianhua Mao, et al.. (2023). Changing prevalence of chronic hepatitis B virus infection in China between 1973 and 2021: a systematic literature review and meta-analysis of 3740 studies and 231 million people. Gut. 72(12). 2354–2363. 58 indexed citations

13.

Guo, Chengnan, et al.. (2023). Composite Interventions on Outcomes of Severely and Critically Ill Patients with COVID-19 in Shanghai, China. Microorganisms. 11(7). 1859–1859. 7 indexed citations

14.

Jiang, Depeng, Yanan Wang, Hui Wang, et al.. (2023). Impact of sarcosine on diabetic retinopathy: Findings based on weighted gene co‐expression network analysis and machine learning techniques. Diabetes Obesity and Metabolism. 25(12). 3501–3511.

15.

Guo, Chengnan, Zhenqiu Liu, Hong Fan, et al.. (2023). Associations of healthy lifestyle and three latent socioeconomic status patterns with physical multimorbidity among middle-aged and older adults in China. Preventive Medicine. 175. 107693–107693. 15 indexed citations

16.

Cai, Feifei, et al.. (2021). Assessing the accuracy of ultrasound measurements of tracheal diameter: an in vitro experimental study. BMC Anesthesiology. 21(1). 177–177. 7 indexed citations

17.

Du, Xia, Chengnan Guo, & Xiaodong Bao. (2021). A Powerful Nomogram Based on the Novel D-Index to Predict Prognosis After Surgical Resection of Hepatocellular Carcinoma. Cancer Management and Research. Volume 13. 2581–2594. 5 indexed citations

18.

Zhao, Shuzhen, Sheng‐Yao Wang, Yanping Xu, et al.. (2021). Serum ω-6/ω-3 polyunsaturated fatty acids ratio and diabetic retinopathy: A propensity score matching based case-control study in China. EClinicalMedicine. 39. 101089–101089. 14 indexed citations

19.

Hou, Xiangqing, Dayong Wang, Jingjing Zuo, et al.. (2019). Development and validation of a prognostic nomogram for HIV/AIDS patients who underwent antiretroviral therapy: Data from a China population-based cohort. EBioMedicine. 48. 414–424. 24 indexed citations

20.

Yu, Maohe, Chengnan Guo, Yi Liu, et al.. (2019). Using latent class analysis to identify money boys at highest risk of HIV infection. Public Health. 177. 57–65. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact